|

Pralatrexate Injection Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: Folotyn®

Pipeline

Phase 1: 1Phase 3: 1

Top Sponsors

  • Acrotech Biopharma Inc.2

Indications

  • Cancer2
  • Peripheral T Cell Lymphoma1
  • Hematologic Malignancies1
  • Advanced Solid Tumors1

Cerritos, California1 trial

Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairment

TOI Clinical Research

Phase 1

Clovis, California1 trial

To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL

University of California, San Francisco Fresno

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.